(WHBC-27)

This track focuses on the latest research and clinical practices in the diagnosis and treatment of acute coronary syndrome. Emphasis will be placed on innovative therapeutic strategies and their impact on patient outcomes.

This session will explore the complexities of adult congenital heart disease, highlighting recent advancements in surgical techniques and patient management. Discussions will include multidisciplinary approaches to care and long-term outcomes.

This track will delve into the pathophysiology of cardiac arrhythmias and the latest developments in electrophysiology. Participants will discuss novel treatment modalities, including device therapy and pharmacological interventions.

This session will examine the relationship between cerebrovascular disorders and cardiovascular health, focusing on shared risk factors and treatment strategies. Insights into stroke prevention and management will be a key component.

This track will highlight advancements in imaging technologies, including MRI and echocardiography, for the assessment of cardiovascular diseases. The session aims to discuss how these innovations enhance diagnostic accuracy and treatment planning.

This session will address the unique challenges in pediatric cardiology, including congenital heart defects and their management. Emphasis will be placed on innovative surgical techniques and the importance of long-term follow-up.

This track will explore the underlying mechanisms of heart failure, including diastolic dysfunction and its clinical implications. Discussions will focus on contemporary management strategies and emerging therapies.

This session will address the ethical dilemmas faced in cardiac surgery, including patient consent and resource allocation. Participants will engage in discussions about the implications of emerging technologies on ethical practices.

This track will cover the latest research in vascular diseases, including arterial occlusive diseases and thrombosis. Emphasis will be placed on diagnostic advancements and innovative treatment options.

This session will focus on the role of pharmacological agents in the management of cardiac conditions, including arrhythmias and heart failure. Participants will discuss recent clinical trials and their implications for practice.

This track will explore the impact of emerging technologies, such as telemedicine and wearable devices, on cardiac care. Discussions will focus on how these innovations can improve patient outcomes and enhance healthcare delivery.